Cellectar Biosciences (CLRB)
(Delayed Data from NSDQ)
$2.03 USD
-0.01 (-0.49%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $2.02 -0.01 (-0.49%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.35 |
EPS Last Quarter | -0.51 |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.91 |
Next Year | -0.25 |
EPS (TTM) | -2.39 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 65.16M |
# of Estimates | NA | NA | NA | 2 |
High Estimate | NA | NA | NA | 118.42M |
Low Estimate | NA | NA | NA | 11.90M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.35 | -0.36 | -1.91 | -0.25 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.43 | -0.46 | -1.86 | 0.45 |
High Estimate | -0.26 | -0.26 | -1.86 | 0.45 |
Low Estimate | -0.43 | -0.46 | -1.95 | -0.95 |
Year ago EPS | -0.82 | -0.66 | -3.15 | -1.91 |
Year over Year Growth Est. | 57.32% | 45.45% | 39.37% | 86.65% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.35 | -0.36 | -1.91 | -0.25 |
7 Days Ago | -0.35 | -0.36 | -1.91 | -0.25 |
30 Days Ago | -0.35 | -0.36 | -1.91 | -0.25 |
60 Days Ago | -0.35 | -0.36 | -1.91 | -0.25 |
90 Days Ago | -0.37 | -0.36 | -1.81 | -0.65 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.36 | -1.91 | -0.25 |
Zacks Consensus Estimate | -0.35 | -0.36 | -1.91 | -0.25 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.51 | -0.40 | -0.66 | -0.82 | NA |
Estimate | NA | -0.50 | -0.59 | -0.44 | NA |
Difference | NA | 0.10 | -0.07 | -0.38 | -0.12 |
Surprise | NA | 20.00% | -11.86% | -86.36% | -26.07% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more